Microport Scientific (MCRPF) 0.4900 $MCRPF
China Orthopedic Instrument Industry Report, 2014-2017
M2 - Fri Aug 29, 3:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2kp9w6/china_orthopedic) has announced the addition of the "China Orthopedic Instrument Industry Report, 2014-2017" report to their offering. Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale presenting a CAGR of 19.2% during 2009-2013. Trauma products, spine products and joint products are three product segments of orthopedic instruments in China, of which trauma products holding the bulk with 36.9% market share in 2013. Being optimistic about bright future of China orthopedic instrument industry, some foreign and domestic companies are speeding up their layout in orthopedic instrument market though mergers and acquisitions. In 2012, Medtronic, Inc. acquired the most competitive orthopedic device maker in China-- China Kanghui Holdings for USD 816 million; In Jan. 2013, Stryker Corporation bought China's largest trauma product makers-- Trauson Holdings Company Limited for HKD5.9 billion; In Sep. 2011, MicroPort Scientific Corporation entered orthopedic instrument market by purchasing Suzhou Best at transaction value of RMB 110 million, and acquired Wright's OrthoRecon business at USD 290 million in Jan. 2014. Key Topics Covered: 1. Overview of Orthopedic Instrument Industry 2. Development of Global Orthopedic Instrument Industry 3. Development of China Orthopedic Instrument Industry 4. Development Environment of China Orthopedic Instrument Industry 5. Foreign Companies in China 6. Major Chinese Companies 7. Forecast and Outlook Companies Mentioned: - Baimtec Material - Beijing AKEC Medical - Beijing Chunlizhengda Technology & Development - Beijing Lidakang Science and Technology - Johnson & Johnson - Medtronic - Shandong Weigao Group Medical Polymer - Shanghai Kinetic Medical - Stryker - Suzhou AND Science & Technology Development - Suzhou Kangli Orthopedics Instrument - Suzou Xinrong Best Medical Instrument - Tianjin Renli Orthopedic Instrument - Tianjin Walkman Biomaterial - United Orthopedic Corporation - Waston Medical Appliance - Zhejiang Guangci Medical Device - Zimmer For more information visit http://www.researchandmarkets.com/research/2k...orthopedic
China Orthopedic Instrument Industry 2014- Global Industry Size, Share, Trend, Growth and Forecast 2017
PRWeb - Fri Aug 22, 6:16AM CDT
Being optimistic about the bright future of the Chinese orthopedic instrument industry, some foreign and domestic companies are speeding up their layout in orthopedic instrument market though mergers and acquisitions. In 2012, Medtronic, Inc. acquired the most competitive orthopedic device maker in China-- China Kanghui Holdings for USD 816 million; In Jan. 2013, Stryker Corporation bought China's largest trauma product makers-- Trauson Holdings Company Limited for HKD5.9 billion; In Sep. 2011, MicroPort Scientific Corporation entered orthopedic instrument market by purchasing Suzhou Best at transaction value of RMB 110 million, and acquired Wright's OrthoRecon business at USD 290 million in Jan. 2014.
China Orthopedic Instrument Industry Report, 2014-2017 Now Available at ChinaMarketResearchReports.com
PRWeb - Fri Aug 22, 1:31AM CDT
Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale presenting a CAGR of 19.2% during 2009-2013. Trauma products, spine products and joint products are three product segments of orthopedic instruments in China, of which trauma products holding the bulk with 36.9% market share in 2013.
Wright Medical Group, Inc. Reports 2014 Second Quarter Financial Results
Business Wire - Tue Aug 05, 3:00PM CDT
--Second Quarter Sales from Continuing Operations Increase 19% As Reported and 19% Constant Currency
Coronary Stents Market - Global Forecast to 2019
M2 - Mon Jul 28, 5:59AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bczzxn/coronary_stents) has announced the addition of the "Coronary Stents Market - Global Industry Analysis, Size, Share, Pipeline Overview, Growth, Trends and Forecast, 2013 - 2019" report to their offering. A coronary stent is a tubular structured device made of a thin mesh of wire, which may also be coated with a polymer containing a drug, or made of biodegradable materials. Coronary stents are utilized during percutaneous coronary interventions (PCIs) for the treatment of patients suffering from various coronary artery diseases (CADs) such as acute myocardial infarction, angina pectoris and others. At present, several researches are being conducted in the field of coronary stenting, in order to minimize side effects such as restenosis and thrombosis. Certain new and advanced coronary stents such as bio-absorbable stents have been commercialized in the global market, which demonstrate very less or no common side effects of coronary stenting. The market for coronary stents can be broadly classified into three major segments, namely, bare metal stents (BMS), drug eluting stents (DES) and bio-absorbable stents. In 2011, the drug eluting stents segment held the largest share of the global coronary stents market, followed by the bare metal stents market. During the forecast period 2013 to 2019, the demand for bare metal stents is expected to be low and its overall growth will be offset by the increasing demand for other stent variants, mainly bio-absorbable stents. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Coronary Stents Market Overview Chapter 4 Global Coronary Stents Market, by Product Type Chapter 5 Global Coronary Stents Market: Pipeline Overview Chapter 6 Global Coronary Stents Market, by Geography Chapter 7 Recommendations Chapter 8 Company Profiles Companies Mentioned: - Abbott Laboratories, Inc. - amg International GmbH - B. Braun Melsungen AG - Biotronik SE & Co. KG - Boston Scientific Corporation - C. R. Bard, Inc. - Cook Medical, Inc. - Johnson & Johnson - Medtronic, Inc. - MicroPort Scientific Corporation - STENTYS SA - Terumo Corporation For more information visit http://www.researchandmarkets.com/research/bc...ary_stents
Global Electrophysiology Ablation Catheters Market 2014-2018
M2 - Wed Jul 09, 5:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zpds69/global) has announced the addition of the "Global Electrophysiology Ablation Catheters Market 2014-2018" report to their offering. Catheter ablation is a minimally invasive procedure used to remove or destroy faulty electrical pathways from sections of the heart that promote irregular cardiac rhythms (also known as cardiac arrhythmias). Cardiac arrhythmias can be of several types, including atrial fibrillation, atrial flutter, and supraventricular tachycardia. Key Regions: - Americas - EMEA - APAC Key Vendors: - Boston Scientific Corp. - Johnson & Johnson - Medtronic Inc. - St. Jude Medical Inc. Other Prominent Vendors: - Advanced Cardiac Therapeutics Inc. - AtriCure Inc. - BIOTRONIK SE & Co. KG - CardioFocus Inc. - Edwards Lifesciences Corp. - Imricor Medical Systems Inc. - MicroPort Scientific Corp. - PLC Medical Systems Inc. - VIMECON GmbH Key Market Drivers: - Growing Incidence of Cardiac Arrhythmias. - For a full, detailed list, view the report. Key Market Challenges: - Presence of Substitutes. - For a full, detailed list, view the report. Key Market Trends: - High Adoption of Irrigated-tip EP Ablation Catheters. - For a full, detailed list, view the report. Key Questions Answered in this Report: - What will the market size be in 2018 and what will the growth rate be? - What are the key market trends? - What is driving this market? - What are the challenges to market growth? - Who are the key vendors in this market space? Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Market Segmentation by Technology 08. Geographical Segmentation 09. Buying Criteria 10. Market Growth Drivers 11. Drivers and their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Trends and their Impact 16. Vendor Landscape 17. Key Vendor Analysis 18. Other Reports in this Series Companies Mentioned: - Advanced Cardiac Therapeutics Inc. - AtriCure Inc. - BIOTRONIK SE & Co. KG - Boston Scientific Corp. - CardioFocus Inc. - Edwards Lifesciences Corp. - Imricor Medical Systems Inc. - Johnson & Johnson - Medtronic Inc. - MicroPort Scientific Corp. - PLC Medical Systems Inc. - St. Jude Medical Inc. - VIMECON GmbH For more information visit http://www.researchandmarkets.com/research/zpds69/global
MicroPort Orthopedics & MB Innovations Announce Partnership
Business Wire - Thu Jul 03, 10:15AM CDT
MicroPort Orthopedics Inc. ("MPO"
and MB Innovations ("MBI" announced today that the two firms have entered into a multi-product development agreement for orthopedic instruments. MBI will initially provide design and development expertise in support of the development of MPO's portfolio of instruments and instrument systems associated with its Fast Recovery, tissue-sparing approach to hip arthroplasty procedures. During the term of the development agreement, there may be additional development programs initiated to develop other differentiated implants and instruments that are used for both hip and knee arthroplasty procedures.
Global Coronary Stent Market through 2019 - Concise Analysis of the Projected $13 Billion Industry Featuring Abbott Laboratories, Boston Scientific, and Medtronic
M2 - Mon Jun 30, 4:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w9x4q9/global_coronary) has announced the addition of the "Global coronary Stent market through 2019" report to their offering. The global coronary stent market is expected to be over $13 billion by 2019 Increasing PCI procedures triggered by the rising prevalence of CAD, novel technologies in pipeline addressing the unmet needs, uptake of Bioabsorbable stents and impressive growth in APAC region have the potential to upswing the fortunes of the market that has remained stagnant for a few years. The market study takes into account various global clinical studies and pipeline products and it suggests that the coronary stent pipeline is clustered with new generation Drug Eluting Stent (DES), bioactive stents, bioabsorbable technology and stents for the niche segments such as complex and bifurcated vessels. Altering the trend, small to medium size companies from the developing economies are ambitiously conducting clinical studies to win the approvals and expand the use of devices for new indications. The stent market globally and in the developed nations is largely controlled by three players, Abbott Laboratories, Boston Scientific, and Medtronic. While in developing economies, small and medium players from Asia and Europe have a considerable share in terms of volume. This comprehensive, 465 page global strategic business report is authored by team of sector analysts who used rigorous primary and secondary research, robust analytical model to provide strategic insight and to forecast in for all major stent types BMS, DES, Bioabsorbable stents in leading 23 geographies. Key Topics Covered: 1. Charts & Tables 2. Executive Summary 3. Market at a Glance 4. Introduction to Stents 5. Coronary Stents 6. Types of Stents 7. Approvals 8. Competitive Landscape 9. Clinical Studies 10. Coronary Stents - Market Drivers and Restrains 11. Overview: Market trends 12. Approvals Driving the Growth 13. Market Data 14. Company Profiles 15. Recent Events 16. Appendix Companies Mentioned - Abbott Vascular - Alvimedica Medical Technologies - Arterial Remodeling Technologies - Boston Scientific Corporation - Biosensors International - Biotronik SE & Co.kG - CID S.r.l. - Clearstream Technologies Ltd. - Disa Vascular (Pty) Ltd. - Elixir Medical Corporation - Endocor Gmbh - Essen Technology (Beijing) Co., Ltd - Hexacath - Iberhospitex S.A - InspireMD, Inc. - Japan Stent Technology Co., Ltd. - Kyoto Medical - Lepu Medical Technology Co., Ltd. - Medinol - Medtronic, Inc. - Meril Life Sciences Pvt. Ltd. - Micell Technologies, Inc. - MicroPort Scientific Corporation - Minvasys - OrbusNeich - Relisys Medical Devices Limited - Reva Medical, Inc. - Sahajanand Medical Technologies - Stentys - Terumo Medical Corporation For more information visit http://www.researchandmarkets.com/research/w9...l_coronary
MediPoint: Electrophysiology - EU Analysis and Market Forecasts 2020
M2 - Mon Mar 24, 11:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/slft2n/medipoint) has announced the addition of the "MediPoint: Electrophysiology - EU Analysis and Market Forecasts" report to their offering. Still in its infancy, the electrophysiology (EP) device market has seen significant adoption; as more physicians become experienced in diagnostic and ablation techniques, increasing numbers of hospitals purchase supportive equipment, device price-points fall, and efficacy improves. This continued growth is also driven by technological advancements including the emergence of next-generation ablation technologies, improvements in catheter diagnostics, and advancements in lab systems. Further, as imaging modalities improve, patients are exposed to less radiation than ever before, which will only further drive diagnostics. The EP market is dominated by several key players, with the biggest markets being in the US and European Union (EU). With improvements in reimbursement worldwide, as well as advancements of global distribution channels, devices are being sold in more hospitals and ever, and this is only expected to increase. With only a few key players currently in the market, competition remains high as industry leaders fight for valuable market share. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Segment Analysis 5 Market Outlooks by Geography 6 Strategic Competitive Assessment 7 Current and Future Players 8 Pipeline Product Assessment 9 Strategic Deals Analysis 10 Appendix Companies Mentioned - Biosense Webster - Biotronik - Boston Scientific - CardioFocus - CardioInsight - Hansen Medical - Imricor - Japan Lifeline - Magnetecs Corporation - Medtronic - MicroPort Scientific Company - St. Jude Medical - Stereotaxis - Stryker Sustainability Solutions - Topera Medical For more information visit http://www.researchandmarkets.com/research/slft2n/medipoint
MediPoint: Electrophysiology - APAC Analysis and Market Forecasts to 2020
M2 - Thu Mar 20, 10:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/z8kgmv/medipoint) has announced the addition of the "MediPoint: Electrophysiology - APAC Analysis and Market Forecasts" report to their offering. Still in its infancy, the electrophysiology (EP) device market has seen significant adoption; as more physicians become experienced in diagnostic and ablation techniques, increasing numbers of hospitals purchase supportive equipment, device price-points fall, and efficacy improves. This continued growth is also driven by technological advancements including the emergence of next-generation ablation technologies, improvements in catheter diagnostics, and advancements in lab systems. Further, as imaging modalities improve, patients are exposed to less radiation than ever before, which will only further drive diagnostics. Growth in emerging markets is expected to drive sales as developing countries look to implement new EP programs, and hospitals adopt ablation techniques. Lastly, published studies, clinical evidence, and patient awareness will all contribute positively to EP market growth and will provide further evidence of the effectiveness of cardiac catheter ablation. Scope - An overview of electrophysiology, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized APAC electrophysiology market revenue from 2005 to 2013, forecast for 7 years to 2020. - Investigation of current and future market competition for electrophysiology - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the electrophysiology sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Segment Analysis 5 Market Outlooks by Geography 6 Strategic Competitive Assessment 7 Current and Future Players 8 Pipeline Product Assessment 9 Strategic Deals Analysis 10 Appendix Companies Mentioned - Biosense Webster - Biotronik - Boston Scientific - CardioFocus - CardioInsight - Hansen Medical - Imricor - Japan Lifeline - Magnetecs Corporation - Medtronic - MicroPort Scientific Company - St. Jude Medical - Stereotaxis - Stryker Sustainability Solutions - Topera Medical For more information visit http://www.researchandmarkets.com/research/z8kgmv/medipoint
Concise Analysis of the International Intracranial Stents Market
M2 - Thu Mar 13, 6:28AM CDT
Research and Markets (http://www.researchandmarkets.com/research/r4fntp/intracranial) has announced the addition of the "Concise Analysis of the International Intracranial Stents Market" report to their offering. This report analyzes the worldwide markets for Intracranial Stents in US$ Thousands. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a five-year historic analysis is provided for these markets. The report profiles 16 companies including many key and niche players such as: - Admedes Schuessler GmbH - BALT Extrusion - Cardiatis SA - Codman & Shurtleff, Inc. - Covidien PLC - ITGI Medical Ltd. - Medtronic, Inc. - MicroPort Scientific Corporation - OBEX Medical - Penumbra, Inc. - Stryker Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Market Drivers, Issues & Challenges 3. Product Overview 4. Neurovascular Diseases - An Overview 5. Product Introductions & Approvals 6. Recent Industry Activity 7. Focus On Select Players 8. Global Market Perspective III. Market 1. The United States 2. Europe 3. Rest Of World IV. Competitive Landscape Total Companies Profiled: 16 (including Divisions/Subsidiaries - 18) - The United States (7) - Europe (6) - France (1) - Germany (3) - Rest of Europe (2) - Asia-Pacific (Excluding Japan) (4) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/r4...tracranial About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global Electrophysiology Market Value to Almost Double by 2020, as Arrhythmia Incidence Continues to Grow
M2 - Tue Mar 04, 3:40AM CST
Research and Markets (http://www.researchandmarkets.com/research/szcgxs/medipoint) has announced the addition of the "MediPoint: Electrophysiology - Global Analysis and Market Forecasts" report to their offering. Global Electrophysiology Market Value to Almost Double by 2020, as Arrhythmia Incidence Continues to Grow The global electrophysiology (EP) market, consisting of ablation catheters, diagnostic catheters and lab systems, is set to experience rapid growth in value over the coming years, climbing from approximately $1.56 billion in 2013 to $2.93 billion by 2020, at a Compound Annual Growth Rate (CAGR) of 9.5%, says research and consulting firm The authors. The company's new report* forecasts that standard diagnostic catheters will achieve the largest revenue in the EP market by 2020, with a share of $2,493 million, followed by advanced diagnostic catheters and standard ablation catheters, with shares of $1,223 million and $575 million, respectively. According to the authors, this rapid EP industry growth is due to an increasing incidence of arrhythmia, along with rising market penetration of diagnostic and ablation catheters in the Asia-Pacific and South American regions. Rob Littlefield, MSc, Senior Analyst covering Medical Devices, says: Medical centers that support ablation are increasingly desirable as the global occurrence of cardiac dyssynchrony continues to rise. While atrial fibrillation and ventricular fibrillation are the most common indications for treatment, heart failure, diabetes and obesity can all contribute to ongoing rhythm management concerns. The authors states that the current EP market is extremely competitive and dominated by several key players, which must continue to innovate in the face of mounting price pressure and strict regulation, as new entrants battle to gain market share. Up-and-coming technologies in development, including alternative forms of energy such as cryo-, ultrasound- and laser-ablation, as well as advanced mapping and navigation technologies, promise to increase product sales and new account openings. Meanwhile, industry standards continue to develop in relation to ablation strategies for treatment, therefore improving patient outcomes, Littlefield concludes. This report provides a comprehensive analysis of the global electrophysiology market, including development and sales of ablation catheters, diagnostic catheters and lab systems in the US, Germany, Italy, Spain, the UK, France, China, India, Japan and Brazil. Key Topics Covered: List of Tables List of Figures Introduction Industry Overview Segment Analysis Market Outlooks by Market Segment Market Outlooks by Geography Strategic Competitive Assessment Current and Future Players Pipeline Product Assessment Strategic Deals Analysis Appendix List of Tables List of Figures Companies Mentioned Biosense Webster Biotronik Boston Scientific CardioFocus CardioInsight Hansen Medical Imricor Japan Lifeline Magnetecs Corporation Medtronic MicroPort Scientific Company St. Jude Medical Stereotaxis Stryker Sustainability Solutions Topera Medical For more information visit http://www.researchandmarkets.com/research/szcgxs/medipoint About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global Drug-eluting Stent Market 2014-2018: The Biggest Challenge the Market is Facing is the Decline in the ASP of DESs
M2 - Mon Feb 17, 8:46AM CST
Research and Markets (http://www.researchandmarkets.com/research/gprmns/global) has announced the addition of the "Global Drug-eluting Stent Market 2014-2018" report to their offering. The analysts forecast the Global Drug-eluting Stent (DES) market to grow at a CAGR of 5.79 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing prevalence of CVD. The Global Drug-eluting Stent (DES) market has also been witnessing the increasing demand for minimally invasive procedures. However, the decline in the average selling price of drug eluting stents could pose a challenge to the growth of this market. Key vendors dominating this space are Abbott Laboratories, Boston Scientific Corp., Medtronic Inc., and Terumo Corp. Other vendors mentioned in the report are B. Braun Melsungen AG, Biosensors International Ltd., BIOTRONIK SE & Co. KG, Cook Medical Inc., Lepu Medical Technology Co. Ltd., MicroPort Scientific Corp., and Sorin Group USA Inc. Commenting on the report, an analyst from the team said: Increasing demand for minimally-invasive procedures has been witnessed among members of the rapidly aging population across the world, and this is expected to boost the growth of the Global DES market. In addition, the cost efficiencies offered by less invasive methods are likely to increase the demand for the procedures in the near future. Minimally-invasive endovascular procedures are surgeries performed through minute incisions in the body. Such procedures can be used to treat plaque blockages in the arteries of the heart and other vessel walls of peripheral organs such as the kidneys and the brain. The principal advantages of these procedures over conventional surgeries are the short recovery time, the short length of the scars resulting in less physical trauma, low risk of infection, and minimized bleeding, and the shorter hospital stays associated with these surgeries. According to the report, one of the key drivers is the increase in the number of patients suffering from CVD. An unhealthy diet and lack of physical activity are the major factors leading to the increase in the number of people prone to CVD. For more information visit http://www.researchandmarkets.com/research/gprmns/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
3 Catalysts To Catapult Global Coronary Stent Market To $13 Billion by 2019
M2 - Mon Jan 27, 9:45AM CST
Research and Markets (http://www.researchandmarkets.com/research/3rr9nj/3_catalysts_to) has announced the addition of the "3 Catalysts To Catapult Global Coronary Stent Market To $13 Billion" report to their offering. The global coronary stent market is expected to be over $13 billion by 2019, despite the current downward trend in the US, the largest market, and declining selling prices globally. Increasing PCI (percutaneous coronary intervention) procedures triggered by the rising prevalence of CAD (coronary artery disease), novel technologies in pipeline addressing the unmet needs, uptake of Bioabsorbable stents and impressive growth in APAC region have the potential to upswing the fortunes of the market that has remained stagnant for a few years. The market study takes into account various global clinical studies and pipeline products and it suggests that the coronary stent pipeline is clustered with new generation Drug Eluting Stent (DES), bioactive stents, bioabsorbable technology and stents for the niche segments such as complex and bifurcated vessels. Altering the trend, small to medium size companies from the developing economies are ambitiously conducting clinical studies to win the approvals and expand the use of devices for new indications. The stent market globally and in the developed nations is largely controlled by three players - Abbott Laboratories, Boston Scientific, and Medtronic. While in developing economies, small and medium players from Asia and Europe have a considerable share in terms of volume. This comprehensive, 465 page global strategic business report is authored by a team of sector analysts who used rigorous primary and secondary research and robust analytical models to provide strategic insight and to forecast for all major stent types BMS, DES, Bioabsorbable stents in leading 23 geographies. Data at global, continents, economic zones, and country level: - Market size of coronary stents in terms - value and volume (2005-2019) for BMS, DES and Bioabsorbables (Bioresorbable - BVS) - Market growth rates (2005-2019) - Average prices of various stents in all the covered geographies (2005-2019) - Number of PCI procedures - Analytical comparison between different continents and economic regions - Market dynamics - market trends, drivers, restrains, issues, competitive landscape - Detailed pipeline and clinical studies - Product approval status - major geographies - Industry consolidation, partnerships, product launches, approvals and recalls - Detailed company profiles of around 70 companies from different levels of value chain Key Topics Covered: 1. Charts & Tables 2. Executive Summary 3. Market at a Glance 4. Introduction to Stents 5. Coronary Stents 6. Types of Stents 7. Approvals 8. Competitive Landscape 9. Clinical Studies 10.Coronary Stents - Market Drivers and Restrains 11.Overview: Market trends 12.Approvals Driving the Growth 13. Market Data 14.Company Profiles 15.Recent Events 16.Appendix 17. Research Methodology 18. Disclaimer Companies Mentioned Include: - Abbott Vascular - Alvimedica Medical Technologies - Arterial Remodeling Technologies - Boston Scientific Corporation - Biosensors International - Biotronik SE & Co.kG - CID S.r.l. - Clearstream Technologies Ltd. - Disa Vascular (Pty) Ltd. - Elixir Medical Corporation - Endocor Gmbh - Essen Technology (Beijing) Co., Ltd - Hexacath - Iberhospitex S.A - InspireMD, Inc. - Japan Stent Technology Co., Ltd. - Kyoto Medical - Lepu Medical Technology Co., Ltd. - Medinol - Medtronic, Inc. - Meril Life Sciences Pvt. Ltd. - Micell Technologies, Inc. - MicroPort Scientific Corporation - Minvasys - OrbusNeich - Relisys Medical Devices Limited - Terumo Medical Corporation - Translumina - Tryton Medical - Vascular Concepts For more information visit http://www.researchandmarkets.com/research/3r...talysts_to
MicroPort Scientific establishes MicroPort Orthopedics through acquisition of Wright Medical's OrthoRecon business
PR Newswire - Mon Jan 13, 9:53AM CST
MicroPort Scientific Corporation (HK: 0853), announced on January 9, 2014 the closing of the transaction to acquire the OrthoRecon business from Wright Medical Group, Inc. (NASDAQ: WMGI). The transaction establishes MicroPort Orthopedics as the sixth largest multinational hip and knee reconstruction company, with global headquarters in Arlington, Tennessee. As a result of the acquisition, MicroPort now holds U.S. manufacturing, global infrastructure, logistics and operations in the top four global orthopedic markets, as well as established hip and knee franchise brands.
Wright Hip Implant News: Rottenstein Law Group LLP Comments on Hip Division Sale
PRWeb - Fri Jun 21, 4:01AM CDT
The maker of the Wright Conserve and Profemur Z metal hip implants announced on June 19 that it was selling its hips and knees division. The Rottenstein Law Group LLP, which maintains Wright Conserve and Profemur Z lawsuit pages, notes that federal Conserve hip lawsuits were consolidated in court because of the device's serious alleged side effects (In re: Wright Medical Technology, Inc., Conserve Hip Implant Products Liability Litigation, MDL-2329, U.S. District Court for the Northern District of Georgia).
Boston Scientific Corporation Market Share Analysis Report
M2 - Mon Jun 10, 8:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hjv25g/boston_scientific) has announced the addition of the "Boston Scientific Corporation Market Share Analysis" company profile to their offering. This report, Boston Scientific Corporation Market Share Analysis provides in-depth information on Boston Scientific Corporation's market position in the different medical equipment markets it operates in. The report provides Boston Scientific Corporation market share information in six key market categories - Remote Patient Monitoring - Neurostimulation Devices - Cardiac Rhythm Management - Electrophysiology - Interventional Cardiology - Peripheral Vascular Devices. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company's business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts. Scope - Global company shares (in Revenues) information for the key markets Boston Scientific Corporation operates in - Patient Monitoring, Neurology Devices and Cardiovascular Devices - Boston Scientific Corporation's company shares (in Revenues) information for all the key countries the company has presence in - Canada, China, Brazil, United States, Spain, Japan, Italy, Australia, Germany, United Kingdom, India and France. - Boston Scientific Corporation's company shares (in Revenues) information for all the key market categories the company has presence in - Remote Patient Monitoring, Neurostimulation Devices, Cardiac Rhythm Management, Electrophysiology, Interventional Cardiology and Peripheral Vascular Devices. - All the key data-points are for 2011 and cover all the key regions - North America, Europe, Asia Pacific (APAC), South and Central America and Middle East and Africa. - Global corporate-level profile with information on the company's business segments, major products and services, competitors, and locations and subsidiaries. - The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company's value proposition and the business climate it operates in. - Comprehensive coverage of the latest financial deals involving the company and its subsidiaries. Companies Mentioned - Biotronik SE & Co. KG - Medtronic, Inc. - St. Jude Medical, Inc. - Honeywell HomMed LLC - Philips Healthcare - GE Healthcare - Cardiocom, LLC - Robert Bosch Healthcare Systems, Inc. - Schiller AG - Nihon Kohden Corporation - Numera - Cyberonics, Inc. - Sorin S.p.A. - Taisho Biomed Instruments Co., Ltd. - Shree Pacetronix Ltd. - Biosense Webster, Inc. - C. R. Bard, Inc. - Japan Lifeline Co., Ltd. - Abbott Laboratories - Terumo Corporation - Cordis Corporation - Volcano Corporation - Lepu Medical Technology (Beijing) Co., Ltd. - Biosensors International Group, Ltd. - Asahi Intecc Co., Ltd. - MicroPort Scientific Corporation - Goodman Co., Ltd. - Eurocor GmbH - Vascular Concepts Limited - Sahajanand Medical Technologies Pvt. Ltd. - HEXACATH - AlviMedica Medical Technologies Inc. - Shanghai MicroPort Medical (Group) Co.,Ltd. - amg International GmbH - OptiMed Medizinische Instrumente GmbH - B. Braun Melsungen AG - Covidien plc - AngioDynamics, Inc. - Cook Medical Incorporated - W. L. Gore & Associates, Inc. - Bolton Medical, Inc. - Merit Medical Systems, Inc. For more information visit http://www.researchandmarkets.com/research/hj...scientific About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
China Orthopedic Instrument Industry Report, 2014-2017
M2 - Fri Aug 29, 3:30AM CDT
Research and Markets (http://www.researchandmarkets.com/research/2kp9w6/china_orthopedic) has announced the addition of the "China Orthopedic Instrument Industry Report, 2014-2017" report to their offering. Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale presenting a CAGR of 19.2% during 2009-2013. Trauma products, spine products and joint products are three product segments of orthopedic instruments in China, of which trauma products holding the bulk with 36.9% market share in 2013. Being optimistic about bright future of China orthopedic instrument industry, some foreign and domestic companies are speeding up their layout in orthopedic instrument market though mergers and acquisitions. In 2012, Medtronic, Inc. acquired the most competitive orthopedic device maker in China-- China Kanghui Holdings for USD 816 million; In Jan. 2013, Stryker Corporation bought China's largest trauma product makers-- Trauson Holdings Company Limited for HKD5.9 billion; In Sep. 2011, MicroPort Scientific Corporation entered orthopedic instrument market by purchasing Suzhou Best at transaction value of RMB 110 million, and acquired Wright's OrthoRecon business at USD 290 million in Jan. 2014. Key Topics Covered: 1. Overview of Orthopedic Instrument Industry 2. Development of Global Orthopedic Instrument Industry 3. Development of China Orthopedic Instrument Industry 4. Development Environment of China Orthopedic Instrument Industry 5. Foreign Companies in China 6. Major Chinese Companies 7. Forecast and Outlook Companies Mentioned: - Baimtec Material - Beijing AKEC Medical - Beijing Chunlizhengda Technology & Development - Beijing Lidakang Science and Technology - Johnson & Johnson - Medtronic - Shandong Weigao Group Medical Polymer - Shanghai Kinetic Medical - Stryker - Suzhou AND Science & Technology Development - Suzhou Kangli Orthopedics Instrument - Suzou Xinrong Best Medical Instrument - Tianjin Renli Orthopedic Instrument - Tianjin Walkman Biomaterial - United Orthopedic Corporation - Waston Medical Appliance - Zhejiang Guangci Medical Device - Zimmer For more information visit http://www.researchandmarkets.com/research/2k...orthopedic
China Orthopedic Instrument Industry 2014- Global Industry Size, Share, Trend, Growth and Forecast 2017
PRWeb - Fri Aug 22, 6:16AM CDT
Being optimistic about the bright future of the Chinese orthopedic instrument industry, some foreign and domestic companies are speeding up their layout in orthopedic instrument market though mergers and acquisitions. In 2012, Medtronic, Inc. acquired the most competitive orthopedic device maker in China-- China Kanghui Holdings for USD 816 million; In Jan. 2013, Stryker Corporation bought China's largest trauma product makers-- Trauson Holdings Company Limited for HKD5.9 billion; In Sep. 2011, MicroPort Scientific Corporation entered orthopedic instrument market by purchasing Suzhou Best at transaction value of RMB 110 million, and acquired Wright's OrthoRecon business at USD 290 million in Jan. 2014.
China Orthopedic Instrument Industry Report, 2014-2017 Now Available at ChinaMarketResearchReports.com
PRWeb - Fri Aug 22, 1:31AM CDT
Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale presenting a CAGR of 19.2% during 2009-2013. Trauma products, spine products and joint products are three product segments of orthopedic instruments in China, of which trauma products holding the bulk with 36.9% market share in 2013.
Wright Medical Group, Inc. Reports 2014 Second Quarter Financial Results
Business Wire - Tue Aug 05, 3:00PM CDT
--Second Quarter Sales from Continuing Operations Increase 19% As Reported and 19% Constant Currency
Coronary Stents Market - Global Forecast to 2019
M2 - Mon Jul 28, 5:59AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bczzxn/coronary_stents) has announced the addition of the "Coronary Stents Market - Global Industry Analysis, Size, Share, Pipeline Overview, Growth, Trends and Forecast, 2013 - 2019" report to their offering. A coronary stent is a tubular structured device made of a thin mesh of wire, which may also be coated with a polymer containing a drug, or made of biodegradable materials. Coronary stents are utilized during percutaneous coronary interventions (PCIs) for the treatment of patients suffering from various coronary artery diseases (CADs) such as acute myocardial infarction, angina pectoris and others. At present, several researches are being conducted in the field of coronary stenting, in order to minimize side effects such as restenosis and thrombosis. Certain new and advanced coronary stents such as bio-absorbable stents have been commercialized in the global market, which demonstrate very less or no common side effects of coronary stenting. The market for coronary stents can be broadly classified into three major segments, namely, bare metal stents (BMS), drug eluting stents (DES) and bio-absorbable stents. In 2011, the drug eluting stents segment held the largest share of the global coronary stents market, followed by the bare metal stents market. During the forecast period 2013 to 2019, the demand for bare metal stents is expected to be low and its overall growth will be offset by the increasing demand for other stent variants, mainly bio-absorbable stents. Key Topics Covered: Chapter 1 Introduction Chapter 2 Executive Summary Chapter 3 Global Coronary Stents Market Overview Chapter 4 Global Coronary Stents Market, by Product Type Chapter 5 Global Coronary Stents Market: Pipeline Overview Chapter 6 Global Coronary Stents Market, by Geography Chapter 7 Recommendations Chapter 8 Company Profiles Companies Mentioned: - Abbott Laboratories, Inc. - amg International GmbH - B. Braun Melsungen AG - Biotronik SE & Co. KG - Boston Scientific Corporation - C. R. Bard, Inc. - Cook Medical, Inc. - Johnson & Johnson - Medtronic, Inc. - MicroPort Scientific Corporation - STENTYS SA - Terumo Corporation For more information visit http://www.researchandmarkets.com/research/bc...ary_stents
Global Electrophysiology Ablation Catheters Market 2014-2018
M2 - Wed Jul 09, 5:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zpds69/global) has announced the addition of the "Global Electrophysiology Ablation Catheters Market 2014-2018" report to their offering. Catheter ablation is a minimally invasive procedure used to remove or destroy faulty electrical pathways from sections of the heart that promote irregular cardiac rhythms (also known as cardiac arrhythmias). Cardiac arrhythmias can be of several types, including atrial fibrillation, atrial flutter, and supraventricular tachycardia. Key Regions: - Americas - EMEA - APAC Key Vendors: - Boston Scientific Corp. - Johnson & Johnson - Medtronic Inc. - St. Jude Medical Inc. Other Prominent Vendors: - Advanced Cardiac Therapeutics Inc. - AtriCure Inc. - BIOTRONIK SE & Co. KG - CardioFocus Inc. - Edwards Lifesciences Corp. - Imricor Medical Systems Inc. - MicroPort Scientific Corp. - PLC Medical Systems Inc. - VIMECON GmbH Key Market Drivers: - Growing Incidence of Cardiac Arrhythmias. - For a full, detailed list, view the report. Key Market Challenges: - Presence of Substitutes. - For a full, detailed list, view the report. Key Market Trends: - High Adoption of Irrigated-tip EP Ablation Catheters. - For a full, detailed list, view the report. Key Questions Answered in this Report: - What will the market size be in 2018 and what will the growth rate be? - What are the key market trends? - What is driving this market? - What are the challenges to market growth? - Who are the key vendors in this market space? Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Market Segmentation by Technology 08. Geographical Segmentation 09. Buying Criteria 10. Market Growth Drivers 11. Drivers and their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Trends and their Impact 16. Vendor Landscape 17. Key Vendor Analysis 18. Other Reports in this Series Companies Mentioned: - Advanced Cardiac Therapeutics Inc. - AtriCure Inc. - BIOTRONIK SE & Co. KG - Boston Scientific Corp. - CardioFocus Inc. - Edwards Lifesciences Corp. - Imricor Medical Systems Inc. - Johnson & Johnson - Medtronic Inc. - MicroPort Scientific Corp. - PLC Medical Systems Inc. - St. Jude Medical Inc. - VIMECON GmbH For more information visit http://www.researchandmarkets.com/research/zpds69/global
MicroPort Orthopedics & MB Innovations Announce Partnership
Business Wire - Thu Jul 03, 10:15AM CDT
MicroPort Orthopedics Inc. ("MPO"
and MB Innovations ("MBI" announced today that the two firms have entered into a multi-product development agreement for orthopedic instruments. MBI will initially provide design and development expertise in support of the development of MPO's portfolio of instruments and instrument systems associated with its Fast Recovery, tissue-sparing approach to hip arthroplasty procedures. During the term of the development agreement, there may be additional development programs initiated to develop other differentiated implants and instruments that are used for both hip and knee arthroplasty procedures. Global Coronary Stent Market through 2019 - Concise Analysis of the Projected $13 Billion Industry Featuring Abbott Laboratories, Boston Scientific, and Medtronic
M2 - Mon Jun 30, 4:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/w9x4q9/global_coronary) has announced the addition of the "Global coronary Stent market through 2019" report to their offering. The global coronary stent market is expected to be over $13 billion by 2019 Increasing PCI procedures triggered by the rising prevalence of CAD, novel technologies in pipeline addressing the unmet needs, uptake of Bioabsorbable stents and impressive growth in APAC region have the potential to upswing the fortunes of the market that has remained stagnant for a few years. The market study takes into account various global clinical studies and pipeline products and it suggests that the coronary stent pipeline is clustered with new generation Drug Eluting Stent (DES), bioactive stents, bioabsorbable technology and stents for the niche segments such as complex and bifurcated vessels. Altering the trend, small to medium size companies from the developing economies are ambitiously conducting clinical studies to win the approvals and expand the use of devices for new indications. The stent market globally and in the developed nations is largely controlled by three players, Abbott Laboratories, Boston Scientific, and Medtronic. While in developing economies, small and medium players from Asia and Europe have a considerable share in terms of volume. This comprehensive, 465 page global strategic business report is authored by team of sector analysts who used rigorous primary and secondary research, robust analytical model to provide strategic insight and to forecast in for all major stent types BMS, DES, Bioabsorbable stents in leading 23 geographies. Key Topics Covered: 1. Charts & Tables 2. Executive Summary 3. Market at a Glance 4. Introduction to Stents 5. Coronary Stents 6. Types of Stents 7. Approvals 8. Competitive Landscape 9. Clinical Studies 10. Coronary Stents - Market Drivers and Restrains 11. Overview: Market trends 12. Approvals Driving the Growth 13. Market Data 14. Company Profiles 15. Recent Events 16. Appendix Companies Mentioned - Abbott Vascular - Alvimedica Medical Technologies - Arterial Remodeling Technologies - Boston Scientific Corporation - Biosensors International - Biotronik SE & Co.kG - CID S.r.l. - Clearstream Technologies Ltd. - Disa Vascular (Pty) Ltd. - Elixir Medical Corporation - Endocor Gmbh - Essen Technology (Beijing) Co., Ltd - Hexacath - Iberhospitex S.A - InspireMD, Inc. - Japan Stent Technology Co., Ltd. - Kyoto Medical - Lepu Medical Technology Co., Ltd. - Medinol - Medtronic, Inc. - Meril Life Sciences Pvt. Ltd. - Micell Technologies, Inc. - MicroPort Scientific Corporation - Minvasys - OrbusNeich - Relisys Medical Devices Limited - Reva Medical, Inc. - Sahajanand Medical Technologies - Stentys - Terumo Medical Corporation For more information visit http://www.researchandmarkets.com/research/w9...l_coronary
MediPoint: Electrophysiology - EU Analysis and Market Forecasts 2020
M2 - Mon Mar 24, 11:05AM CDT
Research and Markets (http://www.researchandmarkets.com/research/slft2n/medipoint) has announced the addition of the "MediPoint: Electrophysiology - EU Analysis and Market Forecasts" report to their offering. Still in its infancy, the electrophysiology (EP) device market has seen significant adoption; as more physicians become experienced in diagnostic and ablation techniques, increasing numbers of hospitals purchase supportive equipment, device price-points fall, and efficacy improves. This continued growth is also driven by technological advancements including the emergence of next-generation ablation technologies, improvements in catheter diagnostics, and advancements in lab systems. Further, as imaging modalities improve, patients are exposed to less radiation than ever before, which will only further drive diagnostics. The EP market is dominated by several key players, with the biggest markets being in the US and European Union (EU). With improvements in reimbursement worldwide, as well as advancements of global distribution channels, devices are being sold in more hospitals and ever, and this is only expected to increase. With only a few key players currently in the market, competition remains high as industry leaders fight for valuable market share. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Segment Analysis 5 Market Outlooks by Geography 6 Strategic Competitive Assessment 7 Current and Future Players 8 Pipeline Product Assessment 9 Strategic Deals Analysis 10 Appendix Companies Mentioned - Biosense Webster - Biotronik - Boston Scientific - CardioFocus - CardioInsight - Hansen Medical - Imricor - Japan Lifeline - Magnetecs Corporation - Medtronic - MicroPort Scientific Company - St. Jude Medical - Stereotaxis - Stryker Sustainability Solutions - Topera Medical For more information visit http://www.researchandmarkets.com/research/slft2n/medipoint
MediPoint: Electrophysiology - APAC Analysis and Market Forecasts to 2020
M2 - Thu Mar 20, 10:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/z8kgmv/medipoint) has announced the addition of the "MediPoint: Electrophysiology - APAC Analysis and Market Forecasts" report to their offering. Still in its infancy, the electrophysiology (EP) device market has seen significant adoption; as more physicians become experienced in diagnostic and ablation techniques, increasing numbers of hospitals purchase supportive equipment, device price-points fall, and efficacy improves. This continued growth is also driven by technological advancements including the emergence of next-generation ablation technologies, improvements in catheter diagnostics, and advancements in lab systems. Further, as imaging modalities improve, patients are exposed to less radiation than ever before, which will only further drive diagnostics. Growth in emerging markets is expected to drive sales as developing countries look to implement new EP programs, and hospitals adopt ablation techniques. Lastly, published studies, clinical evidence, and patient awareness will all contribute positively to EP market growth and will provide further evidence of the effectiveness of cardiac catheter ablation. Scope - An overview of electrophysiology, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized APAC electrophysiology market revenue from 2005 to 2013, forecast for 7 years to 2020. - Investigation of current and future market competition for electrophysiology - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the electrophysiology sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Segment Analysis 5 Market Outlooks by Geography 6 Strategic Competitive Assessment 7 Current and Future Players 8 Pipeline Product Assessment 9 Strategic Deals Analysis 10 Appendix Companies Mentioned - Biosense Webster - Biotronik - Boston Scientific - CardioFocus - CardioInsight - Hansen Medical - Imricor - Japan Lifeline - Magnetecs Corporation - Medtronic - MicroPort Scientific Company - St. Jude Medical - Stereotaxis - Stryker Sustainability Solutions - Topera Medical For more information visit http://www.researchandmarkets.com/research/z8kgmv/medipoint
Concise Analysis of the International Intracranial Stents Market
M2 - Thu Mar 13, 6:28AM CDT
Research and Markets (http://www.researchandmarkets.com/research/r4fntp/intracranial) has announced the addition of the "Concise Analysis of the International Intracranial Stents Market" report to their offering. This report analyzes the worldwide markets for Intracranial Stents in US$ Thousands. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a five-year historic analysis is provided for these markets. The report profiles 16 companies including many key and niche players such as: - Admedes Schuessler GmbH - BALT Extrusion - Cardiatis SA - Codman & Shurtleff, Inc. - Covidien PLC - ITGI Medical Ltd. - Medtronic, Inc. - MicroPort Scientific Corporation - OBEX Medical - Penumbra, Inc. - Stryker Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Market Drivers, Issues & Challenges 3. Product Overview 4. Neurovascular Diseases - An Overview 5. Product Introductions & Approvals 6. Recent Industry Activity 7. Focus On Select Players 8. Global Market Perspective III. Market 1. The United States 2. Europe 3. Rest Of World IV. Competitive Landscape Total Companies Profiled: 16 (including Divisions/Subsidiaries - 18) - The United States (7) - Europe (6) - France (1) - Germany (3) - Rest of Europe (2) - Asia-Pacific (Excluding Japan) (4) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/r4...tracranial About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global Electrophysiology Market Value to Almost Double by 2020, as Arrhythmia Incidence Continues to Grow
M2 - Tue Mar 04, 3:40AM CST
Research and Markets (http://www.researchandmarkets.com/research/szcgxs/medipoint) has announced the addition of the "MediPoint: Electrophysiology - Global Analysis and Market Forecasts" report to their offering. Global Electrophysiology Market Value to Almost Double by 2020, as Arrhythmia Incidence Continues to Grow The global electrophysiology (EP) market, consisting of ablation catheters, diagnostic catheters and lab systems, is set to experience rapid growth in value over the coming years, climbing from approximately $1.56 billion in 2013 to $2.93 billion by 2020, at a Compound Annual Growth Rate (CAGR) of 9.5%, says research and consulting firm The authors. The company's new report* forecasts that standard diagnostic catheters will achieve the largest revenue in the EP market by 2020, with a share of $2,493 million, followed by advanced diagnostic catheters and standard ablation catheters, with shares of $1,223 million and $575 million, respectively. According to the authors, this rapid EP industry growth is due to an increasing incidence of arrhythmia, along with rising market penetration of diagnostic and ablation catheters in the Asia-Pacific and South American regions. Rob Littlefield, MSc, Senior Analyst covering Medical Devices, says: Medical centers that support ablation are increasingly desirable as the global occurrence of cardiac dyssynchrony continues to rise. While atrial fibrillation and ventricular fibrillation are the most common indications for treatment, heart failure, diabetes and obesity can all contribute to ongoing rhythm management concerns. The authors states that the current EP market is extremely competitive and dominated by several key players, which must continue to innovate in the face of mounting price pressure and strict regulation, as new entrants battle to gain market share. Up-and-coming technologies in development, including alternative forms of energy such as cryo-, ultrasound- and laser-ablation, as well as advanced mapping and navigation technologies, promise to increase product sales and new account openings. Meanwhile, industry standards continue to develop in relation to ablation strategies for treatment, therefore improving patient outcomes, Littlefield concludes. This report provides a comprehensive analysis of the global electrophysiology market, including development and sales of ablation catheters, diagnostic catheters and lab systems in the US, Germany, Italy, Spain, the UK, France, China, India, Japan and Brazil. Key Topics Covered: List of Tables List of Figures Introduction Industry Overview Segment Analysis Market Outlooks by Market Segment Market Outlooks by Geography Strategic Competitive Assessment Current and Future Players Pipeline Product Assessment Strategic Deals Analysis Appendix List of Tables List of Figures Companies Mentioned Biosense Webster Biotronik Boston Scientific CardioFocus CardioInsight Hansen Medical Imricor Japan Lifeline Magnetecs Corporation Medtronic MicroPort Scientific Company St. Jude Medical Stereotaxis Stryker Sustainability Solutions Topera Medical For more information visit http://www.researchandmarkets.com/research/szcgxs/medipoint About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global Drug-eluting Stent Market 2014-2018: The Biggest Challenge the Market is Facing is the Decline in the ASP of DESs
M2 - Mon Feb 17, 8:46AM CST
Research and Markets (http://www.researchandmarkets.com/research/gprmns/global) has announced the addition of the "Global Drug-eluting Stent Market 2014-2018" report to their offering. The analysts forecast the Global Drug-eluting Stent (DES) market to grow at a CAGR of 5.79 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing prevalence of CVD. The Global Drug-eluting Stent (DES) market has also been witnessing the increasing demand for minimally invasive procedures. However, the decline in the average selling price of drug eluting stents could pose a challenge to the growth of this market. Key vendors dominating this space are Abbott Laboratories, Boston Scientific Corp., Medtronic Inc., and Terumo Corp. Other vendors mentioned in the report are B. Braun Melsungen AG, Biosensors International Ltd., BIOTRONIK SE & Co. KG, Cook Medical Inc., Lepu Medical Technology Co. Ltd., MicroPort Scientific Corp., and Sorin Group USA Inc. Commenting on the report, an analyst from the team said: Increasing demand for minimally-invasive procedures has been witnessed among members of the rapidly aging population across the world, and this is expected to boost the growth of the Global DES market. In addition, the cost efficiencies offered by less invasive methods are likely to increase the demand for the procedures in the near future. Minimally-invasive endovascular procedures are surgeries performed through minute incisions in the body. Such procedures can be used to treat plaque blockages in the arteries of the heart and other vessel walls of peripheral organs such as the kidneys and the brain. The principal advantages of these procedures over conventional surgeries are the short recovery time, the short length of the scars resulting in less physical trauma, low risk of infection, and minimized bleeding, and the shorter hospital stays associated with these surgeries. According to the report, one of the key drivers is the increase in the number of patients suffering from CVD. An unhealthy diet and lack of physical activity are the major factors leading to the increase in the number of people prone to CVD. For more information visit http://www.researchandmarkets.com/research/gprmns/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
3 Catalysts To Catapult Global Coronary Stent Market To $13 Billion by 2019
M2 - Mon Jan 27, 9:45AM CST
Research and Markets (http://www.researchandmarkets.com/research/3rr9nj/3_catalysts_to) has announced the addition of the "3 Catalysts To Catapult Global Coronary Stent Market To $13 Billion" report to their offering. The global coronary stent market is expected to be over $13 billion by 2019, despite the current downward trend in the US, the largest market, and declining selling prices globally. Increasing PCI (percutaneous coronary intervention) procedures triggered by the rising prevalence of CAD (coronary artery disease), novel technologies in pipeline addressing the unmet needs, uptake of Bioabsorbable stents and impressive growth in APAC region have the potential to upswing the fortunes of the market that has remained stagnant for a few years. The market study takes into account various global clinical studies and pipeline products and it suggests that the coronary stent pipeline is clustered with new generation Drug Eluting Stent (DES), bioactive stents, bioabsorbable technology and stents for the niche segments such as complex and bifurcated vessels. Altering the trend, small to medium size companies from the developing economies are ambitiously conducting clinical studies to win the approvals and expand the use of devices for new indications. The stent market globally and in the developed nations is largely controlled by three players - Abbott Laboratories, Boston Scientific, and Medtronic. While in developing economies, small and medium players from Asia and Europe have a considerable share in terms of volume. This comprehensive, 465 page global strategic business report is authored by a team of sector analysts who used rigorous primary and secondary research and robust analytical models to provide strategic insight and to forecast for all major stent types BMS, DES, Bioabsorbable stents in leading 23 geographies. Data at global, continents, economic zones, and country level: - Market size of coronary stents in terms - value and volume (2005-2019) for BMS, DES and Bioabsorbables (Bioresorbable - BVS) - Market growth rates (2005-2019) - Average prices of various stents in all the covered geographies (2005-2019) - Number of PCI procedures - Analytical comparison between different continents and economic regions - Market dynamics - market trends, drivers, restrains, issues, competitive landscape - Detailed pipeline and clinical studies - Product approval status - major geographies - Industry consolidation, partnerships, product launches, approvals and recalls - Detailed company profiles of around 70 companies from different levels of value chain Key Topics Covered: 1. Charts & Tables 2. Executive Summary 3. Market at a Glance 4. Introduction to Stents 5. Coronary Stents 6. Types of Stents 7. Approvals 8. Competitive Landscape 9. Clinical Studies 10.Coronary Stents - Market Drivers and Restrains 11.Overview: Market trends 12.Approvals Driving the Growth 13. Market Data 14.Company Profiles 15.Recent Events 16.Appendix 17. Research Methodology 18. Disclaimer Companies Mentioned Include: - Abbott Vascular - Alvimedica Medical Technologies - Arterial Remodeling Technologies - Boston Scientific Corporation - Biosensors International - Biotronik SE & Co.kG - CID S.r.l. - Clearstream Technologies Ltd. - Disa Vascular (Pty) Ltd. - Elixir Medical Corporation - Endocor Gmbh - Essen Technology (Beijing) Co., Ltd - Hexacath - Iberhospitex S.A - InspireMD, Inc. - Japan Stent Technology Co., Ltd. - Kyoto Medical - Lepu Medical Technology Co., Ltd. - Medinol - Medtronic, Inc. - Meril Life Sciences Pvt. Ltd. - Micell Technologies, Inc. - MicroPort Scientific Corporation - Minvasys - OrbusNeich - Relisys Medical Devices Limited - Terumo Medical Corporation - Translumina - Tryton Medical - Vascular Concepts For more information visit http://www.researchandmarkets.com/research/3r...talysts_to
MicroPort Scientific establishes MicroPort Orthopedics through acquisition of Wright Medical's OrthoRecon business
PR Newswire - Mon Jan 13, 9:53AM CST
MicroPort Scientific Corporation (HK: 0853), announced on January 9, 2014 the closing of the transaction to acquire the OrthoRecon business from Wright Medical Group, Inc. (NASDAQ: WMGI). The transaction establishes MicroPort Orthopedics as the sixth largest multinational hip and knee reconstruction company, with global headquarters in Arlington, Tennessee. As a result of the acquisition, MicroPort now holds U.S. manufacturing, global infrastructure, logistics and operations in the top four global orthopedic markets, as well as established hip and knee franchise brands.
Wright Hip Implant News: Rottenstein Law Group LLP Comments on Hip Division Sale
PRWeb - Fri Jun 21, 4:01AM CDT
The maker of the Wright Conserve and Profemur Z metal hip implants announced on June 19 that it was selling its hips and knees division. The Rottenstein Law Group LLP, which maintains Wright Conserve and Profemur Z lawsuit pages, notes that federal Conserve hip lawsuits were consolidated in court because of the device's serious alleged side effects (In re: Wright Medical Technology, Inc., Conserve Hip Implant Products Liability Litigation, MDL-2329, U.S. District Court for the Northern District of Georgia).
Boston Scientific Corporation Market Share Analysis Report
M2 - Mon Jun 10, 8:50AM CDT
Research and Markets (http://www.researchandmarkets.com/research/hjv25g/boston_scientific) has announced the addition of the "Boston Scientific Corporation Market Share Analysis" company profile to their offering. This report, Boston Scientific Corporation Market Share Analysis provides in-depth information on Boston Scientific Corporation's market position in the different medical equipment markets it operates in. The report provides Boston Scientific Corporation market share information in six key market categories - Remote Patient Monitoring - Neurostimulation Devices - Cardiac Rhythm Management - Electrophysiology - Interventional Cardiology - Peripheral Vascular Devices. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company's business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by a team of industry experts. Scope - Global company shares (in Revenues) information for the key markets Boston Scientific Corporation operates in - Patient Monitoring, Neurology Devices and Cardiovascular Devices - Boston Scientific Corporation's company shares (in Revenues) information for all the key countries the company has presence in - Canada, China, Brazil, United States, Spain, Japan, Italy, Australia, Germany, United Kingdom, India and France. - Boston Scientific Corporation's company shares (in Revenues) information for all the key market categories the company has presence in - Remote Patient Monitoring, Neurostimulation Devices, Cardiac Rhythm Management, Electrophysiology, Interventional Cardiology and Peripheral Vascular Devices. - All the key data-points are for 2011 and cover all the key regions - North America, Europe, Asia Pacific (APAC), South and Central America and Middle East and Africa. - Global corporate-level profile with information on the company's business segments, major products and services, competitors, and locations and subsidiaries. - The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company's value proposition and the business climate it operates in. - Comprehensive coverage of the latest financial deals involving the company and its subsidiaries. Companies Mentioned - Biotronik SE & Co. KG - Medtronic, Inc. - St. Jude Medical, Inc. - Honeywell HomMed LLC - Philips Healthcare - GE Healthcare - Cardiocom, LLC - Robert Bosch Healthcare Systems, Inc. - Schiller AG - Nihon Kohden Corporation - Numera - Cyberonics, Inc. - Sorin S.p.A. - Taisho Biomed Instruments Co., Ltd. - Shree Pacetronix Ltd. - Biosense Webster, Inc. - C. R. Bard, Inc. - Japan Lifeline Co., Ltd. - Abbott Laboratories - Terumo Corporation - Cordis Corporation - Volcano Corporation - Lepu Medical Technology (Beijing) Co., Ltd. - Biosensors International Group, Ltd. - Asahi Intecc Co., Ltd. - MicroPort Scientific Corporation - Goodman Co., Ltd. - Eurocor GmbH - Vascular Concepts Limited - Sahajanand Medical Technologies Pvt. Ltd. - HEXACATH - AlviMedica Medical Technologies Inc. - Shanghai MicroPort Medical (Group) Co.,Ltd. - amg International GmbH - OptiMed Medizinische Instrumente GmbH - B. Braun Melsungen AG - Covidien plc - AngioDynamics, Inc. - Cook Medical Incorporated - W. L. Gore & Associates, Inc. - Bolton Medical, Inc. - Merit Medical Systems, Inc. For more information visit http://www.researchandmarkets.com/research/hj...scientific About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
